Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: The LIFE study

Journal of Human Hypertension

Volumn 18, Issue 6, 2004, Pages 423-430

  Palmieri, V ^a,g   Wachtell, K ^b   Bella, J N ^a   Gerdts, E ^c   Papademetriou, V ^d   Nieminen, M S ^e   Dahlof B ^f   Roman, M J ^a   Devereux, Richard B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^g FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

Echocardiography; Function; Hypertrophy; Left ventricle

Indexed keywords

ATENOLOL; LOSARTAN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY HEIGHT; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; GENDER; GEOMETRY; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE RELAXATION; HEART LEFT VENTRICLE WALL; HEART STROKE VOLUME; HUMAN; HYPERTENSION; INDIVIDUALIZATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION;

AGED; AGED, 80 AND OVER; DIASTOLE; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 2942737256     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001719     Document Type: Article

References (42)

1. Devereux RB et al. Left ventricular systolic dysfunction in a biracial sample of hypertensive adults: The Hypertension Genetic Epidemiology Network (HyperGEN) Study. Hypertension 2001; 38: 417-423.
2. Bella JN et al. Relationship between left ventricular diastolic relaxation and systolic function in hypertension: The Hypertension Genetic Epidemiology Network (HyperGEN) Study. Hypertension 2001; 38: 424-428.
3. Levy D et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
4. Koren MJ et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
5. Liao Y et al. The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA 1995; 273: 1592-1597.
6. de Simone G et al. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996; 93: 259-265.
7. Aurigemma GP et al. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. J Am Coll Cardiol 2001; 37: 1042-1048.
8. Bella JN et al. Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study. Circulation 2002; 105: 1928-1933.
9. de Simone G et al. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 1998; 31: 1077-1082.
10. Palmieri V et al. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass. Hypertension 1999; 34: 1032-1040, [Erratum in Hypertension 2000; 36: 147].
11. Palmieri V et al. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study. Am Heart J 2001; 141: 784-791.
12. Mureddu GF et al. Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy. J Hypertens 2001; 19: 1113-1119.
13. de Simone G et al. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension 2002; 40: 470-476.
14. Dahlof B et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension. Hypertension 1998; 32: 989-997.
15. Wachtell K et al. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE study. Hypertension 2000; 35: 6-12.
16. Devereux RB et al. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study. Blood Press 2001; 10: 74-82.
17. Devereux RB et al. Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertension. J Hypertens 2000; 18: 1129-1138.
18. Palmieri V et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular Enlargement. J Am Coll Cardiol 1999; 34: 1625-1632.
19. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
20. Devereux RB, Roman JM. Evaluation of cardiac and vascular structure by echocardiography and other noninvasive techniques. In: Laragh JH, Brenner BM. (eds). Hypertension: Pathophysiology, Diagnosis, Treatment. Raven Press: New York, NY, 1995, pp 1969-1985.
21. Schiller NB et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
22. Devereux RB et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
23. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976; 37: 7-11.
24. Devereux RB et al. Relations of Doppler stroke volume and its components to left ventricular stroke volume in normotensive and hypertensive American Indians: the Strong Heart Study. Am J Hypertens 1997; 10: 619-628.
25. Kennedy JW et al. Quantitative angiocardiography. I. The normal left ventricle in man. Circulation 1966; 34: 272-278.
26. de Simone G et al. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23: 1444-1451, [erratum in J Am Coll Cardiol 1994; 24 : 844].
27. Palmieri V et al. Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study). Am J Cardiol 1999; 84: 558-562.
28. Roman MJ, Devereux RB, Cody RJ. Ability of left ventricular stress-shortening relations, end-systolic stress/volume ratio and indirect indexes to detect severe contractile failure in ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 64: 1338-1343.
29. do Simone G, Devereux RB, Celentano A, Roman MJ. Left ventricular chamber and wall mechanics in the presence of concentric geometry. J Hypertens 1999; 17: 1001-1006.
30. de Simone G et al. Relation of left ventricular diastolic properties to systolic function in arterial hypertension. Circulation 2000; 101: 152-157.
31. Devereux RB et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol 2000; 86: 1090-1096.
32. Gandhi SK et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001; 344: 17-22.
33. Schussheim AE et al. Usefulness of subnormal midwall fractional shortening in predicting left ventricular exercise dysfunction in asymptomatic patients with systemic hypertension. Am J Cardiol 1997; 79: 1070-1074.
34. Vasan RS, Benjamin EJ, Levy D. Congestive heart failure with normal left ventricular systolic function. Clinical approaches to the diagnosis and treatment of diastolic heart failure. Arch Intern Med 1996; 156: 146-157.
35. Hatle L. Doppler echocardiographic evaluation of diastolic function in hypertensive cardiomyopathies. Eur Heart J 1993; 14 (Suppl J): 88-94.
36. de Simone G et al. Prognostic implications of the compensatory nature of left ventricular mass in arterial hypertension. J Hypertens 2001; 19: 119-125.
37. Celentano A et al. Inappropriate left ventricular mass in normotensive and hypertensive patients. Am J Cardiol 2001; 87: 361-363.
38. Palmieri V et al. Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study). Am J Cardiol 2001; 88: 1163-1168.
39. Collis T et al. Relations of stroke volume and cardiac output to body composition: the strong heart study. Circulation 2001; 103: 820-825.
40. de Simone G et al. Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 1990; 81: 107-117.
41. Verdecchia P et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999; 100: 1802-1807.
42. Celentano A et al. Inappropriate left ventricular mass and angiotensin converting enzyme gene polymorphism. J Hum Hypertens 2001; 15: 811-813.